The metabolic syndrome in overweight and obese children in Amsterdam-West: Which definition identifies children with high risk?;Het metabool syndroom bij kinderen met overgewicht en obesitas in Amsterdam-West: Welke definitie identificeert kinderen met een hoog risico?

Tijdschrift voor Kindergeneeskunde

Volumn 77, Issue 1, 2009, Pages 2-10

  Van Vliet, M ^a   Diamant, M ^a   Van Der Lei, H D W ^a   Budde, H ^b   Von Rosenstiel, I A ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORBID OBESITY; OBESITY; OUTPATIENT DEPARTMENT; PEDIATRICS; PRESCHOOL CHILD; PREVALENCE; REFERENCE VALUE; SCHOOL CHILD;

EID: 62349130214     PISSN: 03767442     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03086345     Document Type: Article

References (32)

1. Dietz WH. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics. 1998;101:518-25.
2. Hurk K van den, Dommelen P van, Buuren S van, et al. Prevalence of overweight and obesity in the Netherlands in 2003 compared to 1980 and 1997. Arch Dis Child. 2007;92:992-5.
3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37: 1595-607.
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285: 2486-97.
5. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469-80.
6. Dekker JM, Diamant M, Nijpels G, Heine RJ. Metabool syndroom: beperkte meerwaarde voor klinische praktijk. Ned Tijdschr Geneeskd. 2005;149: 155-8.
7. Dhuper S, Cohen HW, Daniel J, et al. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc Diabetol. 2007;6:4.
8. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10-4.
9. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-74.
10. Patton HM, Sirlin C, Behling C, et al. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43:413-27.
11. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation. 1996;93:54-9.
12. Pankow JS, Jacobs DR Jr, Steinberger J, et al. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care. 2004;27:775-80.
13. Zimmet P, Alberti G, Kaufman F, et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059-61.
14. Schindhelm RK, Diamant M, Dekker JM, et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev. 2006;22:437-43.
15. Winckel M van, Mil E van. Wanneer is dik té dik? In: Behandelingsstrategieën bij kinderen met overgewicht. Houten: Bohn Stafleu van Loghum, 2001. p. 11-26.
16. Freddriks AM, Buuren S van, Wit JM, Verloove-Vanhorick SP. Body index measurements in 1996-7 compared with 1980. Arch Dis Child. 2000;82:107-12.
17. Fredriks AM, Buuren S van, Jeurissen SE, et al. Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands. Eur J Pediatr. 2003;162:788-93.
18. Fredriks AM, Buuren S van, Jeurissen SE, et al. Height, weight, body mass index and pubertal development references for children of Moroccan origin in The Netherlands. Acta Paediatr. 2004; 93:817-24.
19. Sawa SC, Kourides Y, Tornaritis M, et al. Reference growth curves for cypriot children 6 to 17 years of age. Obes Res. 2001;9:754-62.
20. American Heart Association Special Report. Recommendations for treatment of hyperlipidemia in adults: a joint statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation. 1984;69:1067A-90A.
21. Man SA de, André JL, Bachman H, et al.: Blood pressure in childhood: pooled findings of six European studies. J Hypertens. 1991;9:109-14.
22. Matthews DR Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
23. Keskin M, Kurtoglu S, Kendirci M, et al. Homeostasis model assessment is more reliable man the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:6500-3.
24. Ferrannini E, Balkau B, Coppack SW, et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab. 2007;92:2885-92.
25. de Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-7.
26. Chen W, Srinivasan SR, Li S, et al. Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: the Bogalusa Heart Study. Diabetes Care. 2005;28:126-31.
27. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163: 427-36.
28. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005;112:666-73.
29. Tirosh A, Shai I, Tekes-Manova D, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med. 2005;353:1454-62.
30. Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039-44.
31. Yki-Jarvinen H. Fat in the liver and insulin resistance. Ann Med. 2005;37:347-56.
32. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Lancet. 1999;354:617-21.